Your browser doesn't support javascript.
loading
Outlier analysis for accelerating clinical discovery: An augmented intelligence framework and a systematic review.
Janoudi, Ghayath; Uzun Rada, Mara; Fell, Deshayne B; Ray, Joel G; Foster, Angel M; Giffen, Randy; Clifford, Tammy; Walker, Mark C.
Afiliação
  • Janoudi G; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada.
  • Uzun Rada M; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.
  • Fell DB; Independent Researcher, Ottawa, Canada.
  • Ray JG; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.
  • Foster AM; Departments of Medicine, Health Policy Management and Evaluation, and Obstetrics and Gynecology, St Michael's Hospital, University of Toronto, Toronto, Canada.
  • Giffen R; Faculty of Health Sciences, University of Ottawa, Ottawa, Canada.
  • Clifford T; IBM Canada, IBM, Toronto, Canada.
  • Walker MC; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.
PLOS Digit Health ; 3(5): e0000515, 2024 May.
Article em En | MEDLINE | ID: mdl-38776276
ABSTRACT
Clinical discoveries largely depend on dedicated clinicians and scientists to identify and pursue unique and unusual clinical encounters with patients and communicate these through case reports and case series. This process has remained essentially unchanged throughout the history of modern medicine. However, these traditional methods are inefficient, especially considering the modern-day availability of health-related data and the sophistication of computer processing. Outlier analysis has been used in various fields to uncover unique observations, including fraud detection in finance and quality control in manufacturing. We propose that clinical discovery can be formulated as an outlier problem within an augmented intelligence framework to be implemented on any health-related data. Such an augmented intelligence approach would accelerate the identification and pursuit of clinical discoveries, advancing our medical knowledge and uncovering new therapies and management approaches. We define clinical discoveries as contextual outliers measured through an information-based approach and with a novelty-based root cause. Our augmented intelligence framework has five

steps:

define a patient population with a desired clinical outcome, build a predictive model, identify outliers through appropriate measures, investigate outliers through domain content experts, and generate scientific hypotheses. Recognizing that the field of obstetrics can particularly benefit from this approach, as it is traditionally neglected in commercial research, we conducted a systematic review to explore how outlier analysis is implemented in obstetric research. We identified two obstetrics-related studies that assessed outliers at an aggregate level for purposes outside of clinical discovery. Our findings indicate that using outlier analysis in clinical research in obstetrics and clinical research, in general, requires further development.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: PLOS Digit Health Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: PLOS Digit Health Ano de publicação: 2024 Tipo de documento: Article